The use of a three-dose, monovalent oral rotavirus vaccine — Rotavac (Bharat Biotech International) — was not associated with an increased risk for intussusception during a 3-year trial in India.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.
